Crewe Advisors LLC Trims Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Crewe Advisors LLC lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.7% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 11,067 shares of the biopharmaceutical company’s stock after selling 309 shares during the period. Crewe Advisors LLC’s holdings in Bristol-Myers Squibb […]

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Ann Powell ,Pomalyst Imnovid ,Robertm Plenge ,Bristol Myers Squibb ,Crewe Advisors ,Fisher Asset Management ,Atlas Wealth ,Ethic Inc ,Barclays ,Bristol Myers Squibb Company ,Kowal Investment Group ,Talbot Financial ,Free Report ,Asset Management ,Investment Group ,Myers Squibb Stock Down ,Myers Squibb ,Get Free Report ,Capital Markets ,Atlantic Securities ,Myers Squibb Company ,Visit Holdingschannel ,Bristol Myers Squibb Daily ,Nyse Bmy ,Bmy ,Medical ,11012210 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,